secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0000950170-25-078340
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director George Tidmarsh resigns from Revelation Biosciences board to avoid conflict of interest
--------------------------------------------------------------------------------

- George Tidmarsh, MD, PhD resigned from the Board on May 23, 2025, to avoid conflict with new US governmental agency work.
- Board size reduced from 5 to 4; Lakhmir Chawla, MD reclassified as Class C Director.
- Resignation was not due to any disagreement with the company's operations, policies, or practices.
- Tidmarsh served as a Class C Director for 5 years; term was set to expire at the 2025 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025078340/0000950170-25-078340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025078340/revb-20250523.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-078340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer